Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques.

[1]  Jeffrey E. Lee,et al.  Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators , 2012, Cancer.

[2]  R. Abrams,et al.  Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial , 2011, Annals of Surgical Oncology.

[3]  G. Weiss,et al.  Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer , 2011, Annals of Surgical Oncology.

[4]  M. Porembka,et al.  Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program. , 2010, Journal of the American College of Surgeons.

[5]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[6]  Kenneth J. Chang,et al.  Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement , 2009, Annals of Surgical Oncology.

[7]  R. Abrams,et al.  Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement , 2009, Annals of Surgical Oncology.

[8]  Jeffrey E. Lee,et al.  Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at Pancreaticoduodenectomy , 2008, Annals of surgery.

[9]  Jeffrey E. Lee,et al.  Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. , 2008, Journal of the American College of Surgeons.

[10]  Jeffrey E. Lee,et al.  Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2007, Annals of surgery.

[11]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.

[12]  Christopher H. Crane,et al.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration , 2004, Journal of Gastrointestinal Surgery.

[13]  Jeffrey E. Lee,et al.  Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer , 2011, Journal of Gastrointestinal Surgery.

[14]  G. La Torre,et al.  A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer , 2009, Annals of Surgical Oncology.

[15]  E. Nakakura,et al.  Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.